Skip Navigation LinksHome > March 2014 - Volume 9 - Issue 3 > Contributor Index

March 2014 - Volume 9 - Issue 3 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Author Name Article
Cabillic, Florian PharMD, PhD

Parallel FISH and Immunohistochemical Studies of ALK Status in 3244 Non–Small-Cell Lung Cancers Reveal Major Discordances

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Camidge, D. Ross MD, PhD

Atypical Negative ALK Break-Apart FISH Harboring a Crizotinib-Responsive ALK Rearrangement in Non–Small-Cell Lung Cancer

Purchase Access
Online Only
PDF
+ Favorites
Request Permissions
Campeau, Marie-Pierre MD

Absence of a Relationship between Tumor 18F-fluorodeoxyglucose Standardized Uptake Value and Survival in Patients Treated with Definitive Radiotherapy for Non–Small-Cell Lung...

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Casadio, Caterina

Does Surgery Improve Survival of Patients with Malignant Pleural Mesothelioma?: A Multicenter Retrospective Analysis of 1365 Consecutive Patients

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Catros, Véronique PharMD, PhD

Parallel FISH and Immunohistochemical Studies of ALK Status in 3244 Non–Small-Cell Lung Cancers Reveal Major Discordances

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chan, Chi-Chung PhD

HIP1–ALK, A Novel ALK Fusion Variant that Responds to Crizotinib

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chaturvedi, Anshuman MD, FRCPath

EBUS-TBNA in Elderly Patients with Lung Cancer: Safety and Performance Outcomes

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chen, Heidi PhD

Discovery of New Membrane-Associated Proteins Overexpressed in Small-Cell Lung Cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chen, Kevin X. PhD

HIP1–ALK, A Novel ALK Fusion Variant that Responds to Crizotinib

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chen, Shu-Hui PhD

HIP1–ALK, A Novel ALK Fusion Variant that Responds to Crizotinib

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chen, Xinsheng MS

HIP1–ALK, A Novel ALK Fusion Variant that Responds to Crizotinib

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chiforeanu, Dan Cristian MD

Parallel FISH and Immunohistochemical Studies of ALK Status in 3244 Non–Small-Cell Lung Cancers Reveal Major Discordances

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Cho, B. C. John MD

A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy: The “SMART” Approach for Resectable Malignant Pleural Mesothelioma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Choi, So-Jung

HIP1–ALK, a Novel Fusion Protein Identified in Lung Adenocarcinoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Choi, Yoon-La

HIP1–ALK, a Novel Fusion Protein Identified in Lung Adenocarcinoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Christensen, James PhD

HIP1–ALK, A Novel ALK Fusion Variant that Responds to Crizotinib

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Cohen, Roger B. MD

Phase I Safety and Pharmacokinetic Study of the PI3K/mTOR Inhibitor SAR245409 (XL765) in Combination with Erlotinib in Patients with Advanced Solid Tumors

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Corre, Romain MD

Parallel FISH and Immunohistochemical Studies of ALK Status in 3244 Non–Small-Cell Lung Cancers Reveal Major Discordances

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Crosbie, Philip A. J. PhD, MRCP

EBUS-TBNA in Elderly Patients with Lung Cancer: Safety and Performance Outcomes

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Actions
View